Melanotan 2 side effects

Melanotan 2 side effects range from mild and transient (nausea, flushing) to potentially serious (mole changes, theoretical melanoma risk). Understanding the side effect profile is critical because MT2 acts on multiple melanocortin receptors — not just the MC1R that produces tanning — and the non-selective receptor activation is responsible for most of the compound's unwanted effects.

Melanotan 2 side effects: nausea and flushing

Nausea and facial flushing are the most common melanotan 2 side effects, particularly during the first 1–2 weeks of use. Both are dose-dependent and can be managed through titration. Nausea typically occurs 10–30 minutes after injection and lasts 30–60 minutes. It is caused by MC3R/MC4R activation in the brainstem's area postrema (the chemoreceptor trigger zone for vomiting). Strategies to reduce nausea include starting at 100–250 mcg and titrating up over 3–5 days, dosing before bed so the nausea occurs during sleep, taking ginger or an antihistamine 30 minutes before injection, and avoiding dosing on a full stomach. Facial flushing (warmth and redness in the face) is caused by MC1R activation on vascular smooth muscle cells and typically subsides within 15–30 minutes. It is not harmful but can be cosmetically noticeable.

Melanotan 2 side effects: mole darkening and new mole formation

This is the most clinically significant melanotan 2 side effect for dermatological safety. MT2 stimulates all melanocytes — not just those in normal skin. Melanocytes within existing nevi (moles) are also activated, which causes existing moles and freckles to darken noticeably (often the first visible sign of MT2 activity), new nevi to appear in areas that previously had none, and changes in mole size, color, or border definition.

Melanotan 2 side effects: melanoma risk

The relationship between melanotan 2 and melanoma is the most important safety question, and the honest answer is that it remains unresolved. MT2 stimulates melanocyte proliferation and activity — and melanoma is a malignancy of melanocytes. The theoretical concern is straightforward: activating the same cells that become malignant could accelerate or promote melanoma development. Case reports have described melanoma diagnosis in melanotan 2 users, though no causal relationship has been established — these could be coincidental. The compound has also shown paradoxical potential for photoprotection by increasing eumelanin, which absorbs UV and reduces DNA damage. Currently, the precautionary principle applies: individuals with personal or strong family history of melanoma, atypical mole syndrome (dysplastic nevi), or fair skin with many moles should not use melanotan 2.

Melanotan 2 side effects: libido and sexual function

Melanotan 2 activates MC3R and MC4R in the hypothalamus, which is the neural pathway involved in sexual arousal. The result is a well-documented increase in libido and, in males, spontaneous erections that can occur hours after injection. This side effect was actually the genesis of PT-141 (bremelanotide) — a related compound derived from melanotan 2 that was ultimately FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women. The sexual function effect of MT2 is dose-dependent and more pronounced at higher doses (500+ mcg). Some users consider this a benefit rather than a side effect; others find spontaneous erections inconvenient or disruptive.

Melanotan 2 side effects: appetite suppression

MC4R activation in the hypothalamus suppresses appetite — the same pathway targeted by anti-obesity drugs like setmelanotide (Imcivree). Melanotan 2 users consistently report reduced hunger, particularly during the loading phase. For some users this is a welcome side effect (reduced caloric intake alongside the tanning benefit). For underweight individuals or those with eating disorder history, this appetite suppression can be problematic. The effect is dose-dependent and typically moderates with continued use as the body adapts to chronic MC4R stimulation.

Melanotan 2 side effects: other reported effects

Additional melanotan 2 side effects reported in the community include mild fatigue or drowsiness (typically in the first few hours after injection), injection site irritation (redness, minor swelling — standard for subcutaneous injection), darkening of the lips and gums (melanocytes in these areas are stimulated alongside skin melanocytes), temporary increase in blood pressure (mild, related to vascular MC1R activation), and headache (occasionally reported, typically dose-related and transient).